Background and objective Given that the novel coronavirus disease 2019 (COVID-19) has
become a pandemic, a method to accurately distinguish COVID-19 from community …

Currently, most reliable and commercialized artificial pancreas systems for type 1 diabetes
are hybrid closed-loop systems, which require the user to announce every meal and its size …

Background Accurate dietary assessment remains a challenge, particularly in free-living
settings. Continuous glucose monitoring (CGM) shows promise in optimizing the …

Insulin pumps and other smart devices have recently made significant advancements in the
treatment of diabetes, a disorder that affects people all over the world. The development of …

Objective digital data is scarce yet needed in many domains to enable research that can
transform the standard of healthcare. While data from consumer-grade wearables and …

In classical approaches for an artificial pancreas, continuous glucose monitoring (CGM) is
the only measured variable used for insulin dosing and additional control functions. The …

Background and objective Hybrid automated insulin delivery systems rely on carbohydrate
counting to improve postprandial control in type 1 diabetes. However, this is an extra burden …

The integration of the Internet of Things (IoT) and cloud computing is the most popular
growing technology in the IT world. IoT integrated cloud computing technology can be used …

Technological advancements in glucose sensing, insulin pumps, and closed-loop glucose
control algorithms open new opportunities towards the realization of Artificial Pancreas (AP) …

Objective: A fully automated artificial pancreas requires a meal estimator and predictions of
blood glucose levels (BGL) to handle disturbances during meal times, all without relying on …